OR WAIT null SECS
The company has completed the expansion of its laboratory facilities to accommodate the development of APIs.
Regis Technologies, a US-based contract development and manufacturing organization, announced on Feb. 17, 2021 that it has completed the expansion of its laboratory facilities in Morton Grove, IL to accommodate the development of APIs.
The 9000-ft.2 expansion features additional process chemistry and analytical laboratories, an Inductively coupled plasma mass spectrometry suite, added climate-controlled storage,14 new fume hoods, new kilo-scale reactors, and process safety equipment for reaction calorimetry measurements for secure control and scale-up, the company said in a press release. Additionally, the laboratories come equipped with an advanced variable air volume air system for clean energy-efficient operations.
“Our investment in this new capacity broadens Regis’ capabilities and our flexibility to support the growing need for US-based custom pharma services,” said Joe Miller, PhD, chief technology officer at Regis Technologies, in the press release. “The desire to reduce supply chain risk, ensure quality, and maintain intellectual property is driving a surging interest in domestic on-boarding of API development and manufacturing. This timely expansion allows us to meet this demand, enabling our scientists to support additional API projects as our customers advance their novel drugs to market.”